A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2011
12/21/2011	CN101966260B 治疗糖尿病并发周围神经病变之肢体麻木疼痛的中药胶囊 Concurrent treatment of diabetic peripheral neuropathy, numbness of pain medicine capsules
12/21/2011	CN101953830B 复乳-高压微射流制备中链脂肪酸-维生素c复方脂质体 Double emulsion - microjets preparative high pressure medium chain fatty acid - vitamin c liposomes Compound
12/21/2011	CN101897690B 一种具有降血脂作用的普伐他汀钠组合物及其制备方法 Pravastatin sodium composition and preparation method has the effect of lowering
12/21/2011	CN101829180B 绞股蓝软胶囊制剂及其制备方法 Gynostemma soft capsule and its preparation method
12/21/2011	CN101829158B 一种猪血组合物及其制成的猪血咀嚼片 One kind of composition and made pig pig chewable tablets
12/21/2011	CN101716248B 一种治疗糖尿病足的中药组合物 A treatment for diabetic foot Chinese medicine composition
12/21/2011	CN101671294B 一种从桑叶中连续提取分离1-脱氧野尻霉素(dnj)、黄酮的方法 A method of continuous extraction and separation from mulberry leaves 1- deoxynojirimycin (dnj), flavonoids
12/21/2011	CN101638405B 高纯度丹酚酸b、制备方法及应用 High purity Sal b, preparation method and application
12/21/2011	CN101623365B 白苓健脾颗粒剂及其制备方法 Bai Ling spleen granule and preparation method
12/21/2011	CN101595925B 天麻降压茶及其制备方法 Tianma buck tea and its preparation method
12/21/2011	CN101502585B 花椒属植物提取物及其制备方法和用途 Genus pepper extract and its preparation method and use
12/21/2011	CN101322553B 一种降血脂膳食配方及其加工工艺 One kind of fat diet formulation and processing technology
12/21/2011	CN101263908B 一种降血脂软胶囊保健食品及其制备方法 A soft capsule lowering health food and its preparation method
12/21/2011	CN101194921B 柿叶黄酮提取物的用途 Uses persimmon leaf flavonoid extract
12/20/2011	US8080665 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080548 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
12/20/2011	US8080523 Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
12/20/2011	US8080236 Particulate materials
12/20/2011	CA2526211C [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof
12/20/2011	CA2508226C Novel heterocyclic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
12/20/2011	CA2492924C Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders
12/20/2011	CA2483464C Method for treating obesity
12/20/2011	CA2450589C Isoxazoline compounds having mif antagonist activity
12/20/2011	CA2450221C Compounds for the treatment of metabolic disorders
12/20/2011	CA2326777C Aminocyclohexyl ether compounds and uses thereof
12/15/2011	WO2011156820A2 Compositions, methods and uses for treatment of type 1 diabetes
12/15/2011	WO2011156736A2 Targeted mucosal treatment of obesity and diabetes
12/15/2011	WO2011156715A2 Methods of treating metabolic disorders and cardiovascular diseases
12/15/2011	WO2011156655A2 Novel glp-1 receptor stabilizers and modulators
12/15/2011	WO2011156554A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	WO2011156451A2 Compositions and methods for modulating toll-like receptor 2 activation
12/15/2011	WO2011155705A2 Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol
12/15/2011	WO2011155689A2 Method for preparing an intermediate of pitavastatin or of the salt thereof
12/15/2011	WO2011155518A1 Lipid metabolism-improving agent
12/15/2011	WO2011154711A1 Peptide-carrying nanoparticles
12/15/2011	WO2011154349A2 Fgf21 analogues and derivatives
12/15/2011	WO2011153965A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof
12/15/2011	WO2011153953A1 Crystalline form of benzylbenzene sglt2 inhibitor
12/15/2011	WO2011153817A1 Cyclopeptides used as melanocortin-4 receptor agonist
12/15/2011	WO2011153712A1 Crystalline form of benzylbenzene sglt2 inhibitor
12/15/2011	WO2011153642A1 Leptin and leptin analog conjugates and fusion proteins and uses thereof
12/15/2011	WO2011153583A1 Nociceptin mimetics
12/15/2011	WO2011109837A3 Methods and compositions for treating diabetes with ips derived pancreatic beta-like cells
12/15/2011	WO2011098424A3 Treatment of a metabolic disorder
12/15/2011	WO2010118034A9 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells
12/15/2011	US20110306759 4-isopropylphenyl glucitol compounds as sglt1 inhibitors
12/15/2011	US20110306663 Triheptanoin diet for adult polyglucosan body disease (apbd) treatment
12/15/2011	US20110306642 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
12/15/2011	US20110306637 Modulators of atp-binding cassette transporters
12/15/2011	US20110306636 Oxazole pyridine derivatives useful as s1p1 receptor agonists
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306624 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/15/2011	US20110306623 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
12/15/2011	US20110306612 Quinazolinone, quinolone and related analogs as sirtuin modulators
12/15/2011	US20110306609 Thiazolopyridine sirtuin modulating compounds
12/15/2011	US20110306608 Compositions and methods for treating vascular, autoimmune and inflammatory diseases
12/15/2011	US20110306607 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/15/2011	US20110306603 Large substituent, non-phenolic opioids and methods of use thereof
12/15/2011	US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	US20110306587 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
12/15/2011	US20110306584 Porphyrin Catalysts and Methods of Use Thereof
12/15/2011	US20110306575 Medical and nutritional applications of highly refined cellulose
12/15/2011	US20110306552 Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2
12/15/2011	US20110306544 Methods and formulations for increasing intestinal function
12/15/2011	US20110306543 Combination of insulin with triazine derivatives and its use for treating diabetes
12/15/2011	US20110306542 Novel glp-1 receptor stabilizers and modulators
12/15/2011	US20110306540 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment
12/15/2011	US20110306539 Process for making particles for delivery of drug nanoparticles
12/15/2011	US20110306018 Methods For Improving Pregnancy Outcomes
12/15/2011	US20110305782 Methods of cholesterol reduction using isoflavones
12/15/2011	US20110305781 Use of Eclipta Prostrata and Other PPAR-GAMMA Inhibitors in Cosmetics and Compositions Thereof
12/15/2011	US20110305775 Micronutrient Supplement Dispensing Package
12/15/2011	US20110305771 Krill Extracts for Treatment of Cardiovascular Diseases
12/15/2011	US20110305743 Ocular implant made by a double extrusion process
12/15/2011	US20110305733 Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them
12/15/2011	US20110305729 Scriptaid Isosteres and Their Use in Therapy
12/15/2011	US20110305686 Therapies for chronic renal failure using one or more integrin antagonists
12/15/2011	US20110305679 Blood-Cholesterol-Lowering Strain of Lactobacillus Delbrueckii
12/15/2011	US20110305677 Human embryonic stem cell cultures, and compositions and methods for growing same
12/15/2011	US20110305663 Serum albumin binding molecules
12/15/2011	US20110305643 High Oil-Content Emollient Aerosol Foam Compositions
12/15/2011	US20110305642 Micronutrient supplement
12/15/2011	US20110305636 Compounds, compositions, methods of synthesis, and methods of treatment
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305631 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
12/15/2011	US20110303573 Omega 3 fatty acid formulations
12/15/2011	CA2802184A1 Oral iron deficiency therapy
12/15/2011	CA2802031A1 Peptide-carrying nanoparticles
12/15/2011	CA2801909A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011	CA2801689A1 Agent for improving lipid metabolism
12/15/2011	CA2800379A1 Crystalline form of benzylbenzene sglt2 inhibitor
12/14/2011	EP2394996A1 Phenylimidazole compounds
12/14/2011	EP2393978A1 Method for coating microspheres onto a flexible material
12/14/2011	EP2393926A1 Compositions and methods for inhibiting expression of ptp1b genes
12/14/2011	EP2393810A1 Phthalazine-containing antidiabetic compounds
12/14/2011	EP2393807A1 Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
12/14/2011	EP2240198B1 Composition for absorption through mucous tissue
12/14/2011	EP1893582B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders
12/14/2011	EP1712547B1 Bicycloester derivative

1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1298